289
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Integrating real world data and clinical trial results using survival data reconstruction and marginal moment-balancing weights

, & ORCID Icon
Pages 191-203 | Received 16 Jan 2021, Accepted 08 Oct 2021, Published online: 10 Nov 2021

References

  • Austin, P. C., P. Grootendorst, and G. M. Anderson. 2007. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: A monte carlo study. Statistics in Medicine 26 (4):734–753. doi:10.1002/sim.2580.
  • Bajorin, D. F., P. M. Dodd, M. Mazumdar, M. Fazzari, J. A. McCaffrey, H. I. Scher, H. Herr, G. Higgins, and M. G. Boyle. 1999. Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy. Journal of Clinical Oncology 17 (10):3173–3181. doi:10.1200/JCO.1999.17.10.3173.
  • Birnbaum, B., N. Nussbaum, K. Seidl-Rathkopf, M. Agrawal, M. Estevez, E. Estola, J. Haimson, L. He, P. Larson, and P. Richardson. 2020. Model-assisted cohort selection with bias analysis for generating large-scale cohorts from the ehr for oncology research. arXiv Preprint arXiv:200109765.
  • Carrigan, G., S. Whipple, M. D. Taylor, A. Z. Torres, A. Gossai, B. Arnieri, M. Tucker, P. P. Hofmeister, P. Lambert, S. D. Griffith, et al. 2019. An evaluation of the impact of missing deaths on overall survival analyses of advanced non–small cell lung cancer patients conducted in an electronic health records database. Pharmacoepidemiology and Drug Safety. 28(5):572–581. doi:10.1002/pds.4758.
  • Colon-Otero, G., R. C. Smallridge, L. A. Solberg Jr, T. D. Keith, T. A. Woodward, F. B. Willis, and A. N. Dunn. 2008. Disparities in participation in cancer clinical trials in the United States: A symptom of a healthcare system in crisis. Cancer: Interdisciplinary International Journal of the American Cancer Society 112 (3):447–454. doi:10.1002/cncr.23201.
  • Curtis, M. D., S. D. Griffith, M. Tucker, M. D. Taylor, W. B. Capra, G. Carrigan, B. Holzman, A. Z. Torres, P. You, B. Arnieri, et al. 2018. Development and validation of a high-quality composite real-world mortality endpoint. Health Services Research. 53(6):4460–4476. doi:10.1111/1475-6773.12872.
  • De Santis, M., J. Bellmunt, G. Mead, J. M. Kerst, M. Leahy, P. Maroto, T. Gil, S. Marreaud, G. Daugaard, I. Skoneczna, et al. 2012. Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986. Journal of Clinical Oncology. 30(2):191. doi:10.1200/JCO.2011.37.3571.
  • Guyot, P., A. Ades, M. J. Ouwens, and N. J. Welton. 2012. Enhanced secondary analysis of survival data: Reconstructing the data from published Kaplan-Meier survival curves. BMC Medical Research Methodology 12 (1):9. doi:10.1186/1471-2288-12-9.
  • Hainmueller, J. 2012. Entropy balancing for causal effects: A multivariate reweighting method to produce balanced samples in observational studies. Political Analysis 20:25–46. doi:10.1093/pan/mpr025.
  • Hamel, L. M., L. A. Penner, T. L. Albrecht, E. Heath, C. K. Gwede, and S. Eggly. 2016. Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer. Cancer Control 23 (4):327–337. doi:10.1177/107327481602300404.
  • Koehler, E., E. Brown, and S. J. P. Haneuse. 2009. On the assessment of monte carlo error in simulation-based statistical analyses. The American Statistician 63 (2):155–162. doi:10.1198/tast.2009.0030.
  • Lo, B. 2015. Sharing clinical trial data: Maximizing benefits, minimizing risk. JAMA 313 (8):793–794. doi:10.1001/jama.2015.292.
  • Ma, X., L. Long, S. Moon, B. J. Adamson, and S. S. Baxi. 2020. Comparison of population characteristics in real-world clinical oncology databases in the us: Flatiron health, seer, and npcr. medRxiv. doi:https://doi.org/10.1101/2020.03.16.20037143.
  • Mello, M. M., J. K. Francer, M. Wilenzick, P. Teden, B. E. Bierer, M. Barnes, and M. B. Hamel. 2013. Preparing for responsible sharing of clinical trial data. New England Journal of Medicine 369 (17):1651–1658. doi:10.1056/NEJMhle1309073.
  • Pang, H. H., X. Wang, T. E. Stinchcombe, M. L. Wong, P. Cheng, A. K. Ganti, D. J. Sargent, Y. Zhang, C. Hu, S. J. Mandrekar, et al. 2016. Enrollment trends and disparity among patients with lung cancer in national clinical trials, 1990 to 2012. Journal of Clinical Oncology. 34(33):3992. doi:10.1200/JCO.2016.67.7088.
  • Parikh, R. B., E. K. Feld, M. D. Galsky, B. J. Adamson, A. B. Cohen, S. S. Baxi, S. B. Boursi, J. P. Christodouleas, D. J. Vaughn, N. J. Meropol, et al. 2020. First-line immune checkpoint inhibitor use in cisplatin-eligible patients with advanced urothelial carcinoma: A secular trend analysis. Future Oncology. 16(2):4341–4345. doi:10.2217/fon-2019-0578.
  • Phillippo, D. M., S. Dias, A. Ades, and N. J. Welton. 2020. Equivalence of entropy balancing and the method of moments for matching-adjusted indirect comparison. Research Synthesis Methods 11 (4):568–572. doi:10.1002/jrsm.1416.
  • Ramsey, S. D., B. J. Adamson, X. Wang, D. Bargo, S. S. Baxi, S. Ghosh, and N. J. Meropol. 2020. Using electronic health record data to identify comparator populations for comparative effectiveness research. Journal of Medical Economics 23 (12): 1618–1622.
  • Saluja, R., S. Cheng, K. A. Delos Santos, and K. K. Chan. 2019. Estimating hazard ratios from published Kaplan-Meier survival curves: A methods validation study. Research Synthesis Methods 10 (3):465–475. doi:10.1002/jrsm.1362.
  • Signorovitch, J. E., E. Q. Wu, P. Y. Andrew, C. M. Gerrits, E. Kantor, Y. Bao, S. R. Gupta, and P. M. Mulani. 2010. Comparative effectiveness without head-to-head trials. Pharmacoeconomics 28 (10):935–945. doi:10.2165/11538370-000000000-00000.
  • Wan, X., L. Peng, and Y. Li. 2015. A review and comparison of methods for recreating individual patient data from published Kaplan-Meier survival curves for economic evaluations: A simulation study. PLoS One 10 (3):e0121353. doi:10.1371/journal.pone.0121353.
  • Wan, X., W. Wang, J. Liu, and T. Tong. 2014. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Medical Research Methodology 14 (1):135. doi:10.1186/1471-2288-14-135.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.